← The Wire
SLSNasdaq
SELLAS Life Sciences Group, Inc.
Pharmaceutical Preparations · DE · CIK 1390478
Develops novel cancer therapeutics, including peptide immunotherapy and CDK9 inhibitors
red 8-K · 90d
$1.54B
Market cap
$15.45
Last close
+24.7%
1D
+81.1%
5D
33.1M
Volume
Price · last 39 sessions+207.8%
May 4L $4.87 · H $15.45Jun 29
464
Total filings
Jun 25, 2026
Last filing
12/31
Fiscal year end
8-KExecutive ChangeJun 25, 20268-KShareholder VoteJun 18, 20268-KCompany UpdateJun 2, 20268-KResults of OperationsMay 12, 202610-Q10-QMay 12, 2026DEFA14ADEFA14AApr 23, 2026DEF 14AFORM- DEF 14AApr 23, 20268-KResults of OperationsMar 19, 202610-K10-KMar 19, 20268-KCompany UpdateMar 11, 20268-KResults of Operations · Company UpdateJan 8, 20268-KResults of OperationsNov 12, 202510-Q10-QNov 12, 2025424B5424B5Oct 27, 20258-KMaterial Agreement · Company UpdateOct 27, 20258-KMaterial AgreementOct 3, 20258-KMaterial Agreement · Equity IssuanceSep 11, 20258-KResults of OperationsAug 12, 202510-Q10-QAug 12, 20258-KShareholder VoteJun 18, 2025DEFA14ADEFA14AJun 10, 20258-KAuditor ChangeJun 6, 20258-KResults of OperationsMay 13, 202510-Q10-QMay 13, 2025DEFA14ADEFA14AApr 23, 2025DEF 14ADEF 14AApr 23, 20258-KResults of OperationsMar 20, 202510-K10-KMar 20, 2025424B5424B5Jan 29, 20258-KMaterial Agreement · Company UpdateJan 29, 20258-KReg FD DisclosureJan 23, 20258-KExecutive ChangeJan 16, 20258-KReg FD DisclosureDec 10, 20248-KResults of OperationsNov 13, 202410-Q10-QNov 13, 20248-KMaterial AgreementOct 4, 20248-KResults of OperationsAug 13, 202410-Q10-QAug 13, 20248-KMaterial Agreement · Company UpdateAug 1, 2024424B5424B5Aug 1, 20248-KShareholder VoteJun 21, 20248-KResults of OperationsMay 14, 202410-Q10-QMay 14, 2024DEFA14ADEFA14AApr 29, 2024DEF 14ADEF 14AApr 29, 20248-KResults of OperationsMar 28, 202410-K10-KMar 28, 20248-KCompany UpdateMar 28, 2024424B5424B5Mar 18, 20248-KMaterial Agreement · Company UpdateMar 15, 20248-KCompany UpdateMar 11, 20248-KExecutive Change · Company UpdateMar 8, 20248-KCompany UpdateMar 5, 20248-KDelisting NoticeFeb 16, 2024SC 13GSELLAS LIFE SCIENCES GROUP, INC.Feb 7, 20248-KMaterial Agreement · Company UpdateJan 8, 2024424B5424B5Jan 5, 2024424B5424B5Jan 4, 20248-KAgreement TerminatedJan 3, 20248-KCompany UpdateDec 22, 20238-KMaterial AgreementDec 13, 20238-KDelisting NoticeDec 8, 20238-KResults of OperationsNov 9, 202310-Q10-QNov 9, 2023424B5424B5Nov 1, 20238-KMaterial Agreement · Company UpdateOct 31, 20238-KCompany UpdateOct 16, 20238-KCompany UpdateOct 13, 20238-KResults of OperationsAug 10, 202310-Q10-QAug 10, 20238-KShareholder VoteJun 21, 20238-KReg FD DisclosureJun 1, 20238-KResults of OperationsMay 11, 202310-Q10-QMay 11, 2023DEFA14ADEFA14AApr 28, 2023DEF 14ADEF 14AApr 28, 20238-KResults of OperationsMar 16, 202310-K10-KMar 16, 20238-KReg FD DisclosureMar 10, 20238-KMaterial AgreementMar 1, 2023
Insider Activity
In the 90 days to Nov 19, 2025: 1 insider bought $101K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 19, 2025 | Kalin Katherine BachDirector | Buy | 63,400 | $1.59 | $101K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
In the News
Reputable outlets only (Reuters, WSJ, CNBC, Barron's, and peers). More on Google News ↗
Similar companies
Comparable business profile · signals at a glance